Compare LLY & V Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LLY | V |
|---|---|---|
| Founded | 1876 | 1958 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 818.6B | 676.2B |
| IPO Year | 2007 | 2007 |
| Metric | LLY | V |
|---|---|---|
| Price | $963.44 | $329.19 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 19 | 22 |
| Target Price | ★ $1,218.84 | $394.18 |
| AVG Volume (30 Days) | 2.5M | ★ 5.9M |
| Earning Date | 04-30-2026 | 04-28-2026 |
| Dividend Yield | ★ 0.81% | 0.80% |
| EPS Growth | ★ 95.99 | N/A |
| EPS | ★ 8.26 | N/A |
| Revenue | ★ $65,179,000,000.00 | $21,846,000,000.00 |
| Revenue This Year | $27.15 | $13.85 |
| Revenue Next Year | $16.04 | $10.36 |
| P/E Ratio | $40.76 | ★ $30.09 |
| Revenue Growth | ★ 44.70 | N/A |
| 52 Week Low | $623.78 | $293.89 |
| 52 Week High | $1,133.95 | $375.51 |
| Indicator | LLY | V |
|---|---|---|
| Relative Strength Index (RSI) | 57.87 | 65.09 |
| Support Level | $877.11 | $321.36 |
| Resistance Level | $970.31 | $336.83 |
| Average True Range (ATR) | 25.92 | 5.39 |
| MACD | 5.06 | 2.43 |
| Stochastic Oscillator | 83.65 | 65.77 |
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Visa is the largest payment processor in the world. In fiscal 2025, it processed almost $17 trillion in total volume. Visa operates in over 200 countries and processes transactions in over 160 currencies. Its systems are capable of processing over 65,000 transactions per second.